MEDHERANT
Medherant was founded by Professor David Haddleton and the University of Warwick to develop and commercialise novel transdermal drug delivery platforms. Current patch technologies have limited drug loading capabilities, making them unviable for use with many pharmaceutical products that could benefit from transdermal delivery. Creams and gels on the other hand suffer from a lack of dose control that is critical for many drugs.
MEDHERANT
Industry:
Commercial Delivery Pharmaceutical
Founded:
2015-01-01
Address:
Coventry, Coventry, United Kingdom
Country:
United Kingdom
Website Url:
http://www.medherant.co.uk
Total Employee:
1+
Status:
Active
Contact:
+442476323060
Email Addresses:
[email protected]
Total Funding:
7.64 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Universal Analytics Apache Microsoft Exchange Online Office 365 Mail Google Maps
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Auris Medical
Auris Medical develops novel pharmaceutical therapies to prevent and treat severe inner ear disorders.
OptiNose
OptiNose develops nasal drug delivery technologies and combined drug and device therapies.
Current Employees Featured
Founder
Investors List
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Series A - Medherant
Innovate UK
Innovate UK investment in Grant - Medherant
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Venture Round - Medherant
Mercia Asset Management PLC
Mercia Asset Management PLC investment in Seed Round - Medherant
Official Site Inspections
http://www.medherant.co.uk
- Host name: 165.9.205.92.host.secureserver.net
- IP address: 92.205.9.165
- Location: Germany
- Latitude: 51.4476
- Longitude: 7.0122
- Timezone: Europe/Berlin
